Biotech in Kendall Square

7+ hour, 27+ min ago   (747+ words) China’s advantage is scale across discovery and development, and India in cost-efficiency and innovation footprint. For decades, the global biotechnology map was largely defined by a handful of established centres in the United States, and Europe. Boston, the Bay Area,…...

11+ hour, 33+ min ago   (107+ words) Servier shared on LinkedIn: “We are excited to announce that the next edition of the Servier Partnering Day will take place in our Paris-Saclay R/D Institute on November 23rd! This unique event is designed to bring together pharma and biotech…...

19+ hour, 30+ min ago   (164+ words) Sep 13, 2026, 08:57 ET Anti-B7-H3 antibody-drug conjugate reduced the risk of death by 54% versus topotecan and improved progression-free survival and response rates Relapsed SCLC remains a highly aggressive disease with limited effective treatment options and poor outcomes following first-line immunotherapy and platinum-based…...

1+ day, 8+ hour ago   (328+ words) Tambotatug pelitecan (Tam-Peli) demonstrated statistically significant efficacy over topotecan in a phase III study conducted in China, reducing the risk of death by 54% and disease progression by 71%, while achieving an objective response rate of 59.1% vs 9.7%1 The novel B7-H3-targeted antibody-drug conjugate…...

1+ day, 8+ hour ago   (135+ words) Labcorp has acquired MLM Medical Labs, a global central and specialty laboratory provider with operations across the United States, Germany, and South Africa. Financial terms of the transaction were not disclosed. Following the transaction, Labcorp said it becomes the only…...

1+ day, 3+ hour ago   (270+ words) More than 500 different gene mutations can cause the disease, making mutation-specific treatments impractical. Researchers in Australia have developed a genome editing approach that could provide a more durable treatment for children with a rare genetic liver disorder. Researchers have taken…...

1+ day, 1+ hour ago   (120+ words) Adoptive T cell therapy has delivered striking remissions in some blood cancers, but its promise in solid tumors has been repeatedly undermined by a stubborn problem: the therapeutic cells do not last. Engineered T cells that flood a tumor and…...

1+ day, 7+ hour ago   (533+ words) Patients with small cell lung cancer who have already undergone platinum-based chemotherapy may soon have more flexibility in how they receive one of the field’s most promising new immunotherapies....

1+ day, 11+ hour ago   (202+ words) Frazier Life Sciences has closed more than $1.1 billion in new capital commitments to its Public Fund, pushing the long-only investment vehicle's total committed capital to roughly $2.8 billion. The Palo Alto-based firm announced the raise Thursday, marking one of the largest…...

5+ day, 3+ hour ago   (301+ words) Suboptimal immunosuppression remains one of the most persistent challenges in solid organ transplant medicine, contributing to chronic rejection and premature graft loss for hundreds of thousands of recipients worldwide. Despite advances in short-term survival, long-term graft outcomes have stagnated for…...